secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ensysce Biosciences, Inc. (ENSC)
CIK:        0001716947
Form:       8-K
Filed at:   2026-02-27T23:59:59+00:00
Accession:  0001493152-26-008343
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Ensysce Biosciences receives Nasdaq deficiency notice for bid price below $1
----------------------------------------------------------------------------

- Received Nasdaq deficiency letter on Feb 25, 2026; bid price closed below $1 for 30 consecutive business days.
- Company has 180 days, until August 24, 2026, to regain compliance by closing at $1 for 10 consecutive days.
- If not compliant by Aug 24, Nasdaq may grant a second 180-day period if other listing standards met.
- Company intends to monitor bid price and evaluate options; trading on Nasdaq continues under ENSC.
- Failure to regain compliance could lead to delisting, impairing capital raising and market liquidity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716947/000149315226008343/0001493152-26-008343-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716947/000149315226008343/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-008343

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer